Compositions for reduction of side effects
US9511037B2 · kind B2 · utility
6Cited by
24References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 19, 2012 |
| Grant date | Dec 6, 2016 |
| Priority date | — |
| Expiry date | Oct 19, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides drug therapy formulations. In some embodiments, the present invention provides combinations of pharmaceutical agents (e.g., stimulant and non-stimulant), pharmaceutical formulations (e.g., nanoparticualte, non-nanoparticualte, etc.), and release profiles (e g, immediate release, delayed release, sustained release, etc.) to provide therapeutic benefit with reduced side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.